Open AccessA study to compare the overall effectiveness between midazolam and dexmedetomidine during monitored anesthesia care: A randomized prospective study
Author(s) -
Mohd Asim Rasheed,
D C Punera,
Mehar Bano,
Urmila Palaria,
Abhilasha Tyagi,
Shatrunjay Sharma
Publication year - 2015
Publication title -
al-banǧ. maqālāt wa abḥāṯ fī al-taẖdīr wa-al-in’āš
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/0259-1162.156299
Subject(s) - dexmedetomidine , midazolam , anesthesia , medicine , randomized controlled trial , prospective cohort study , sedation , surgery
Monitored anesthesia care (MAC) combines intravenous sedation along with local anesthetic infiltration or nerve block. Several drugs have been used for MAC, but all are associated with complications. Dexmedetomidine is a selective α2-adrenoceptor agonist with both sedative and analgesic properties and is devoid of respiratory depressant effects. Its short elimination half-life makes it an attractive agent for sedation during MAC.